Description
Single-cell omics analysis technologies are emerging as a disruptive force in the life science research, pharmaceutical and diagnostics industries. Single cell analysis is critical for analyzing complex, heterogeneous biological systems that occur at many levels of life sciences from stem cell biology to cancer to forensics.
In cancer, for example, a tumor may shed cells into the bloodstream that give clues about the aggressiveness of that tumor or how it is responding to a particular drug therapy. It is important to analyze these individual cells, called circulating tumor cells, to aid in monitoring the disease or to guide therapy strategies. The emerging field of liquid biopsy addresses this medical need.
Single-cell omics are also important to fundamental biological research, for example, to identify cancer mutation drivers or factors that influence stem cell potency. The trend toward biological drugs, stem cell therapies and new cancer treatments is also beneficial to the single cell analysis markets due to its importance in these fields.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3163483-single-cell-omics-emerging-technologies-and-markets
Reasons for Doing This Study:
The life science industry is moving towards digitization with the advent of newer technologies including advanced genetic sequencing and microfluidics systems. As many biological systems contain heterogeneous populations of cells, heretofore many analysis methods measured mixtures of different cell types.
Single cell analysis is a disruptive technology that enables analysis of single cells out of a complex mixture of cells. This type of analysis is key to understanding complex systems in fields as diverse as neurology, stem cell biology and cancer.
At the same time, advances in genome editing, high-throughput systems and microfluidics technologies have enabled the rapid, parallel analysis of smaller samples that are common with single cells. Based on this, single cell analysis markets are rapidly emerging and the need for industry and market characterization is great.
Also, the single cell field is growing beyond basic research into applied fields and molecular diagnostics applications.
The outstanding growth potential for single cell analysis products makes it particularly timely for doing this updated report.
Report Scope:
The scope of this report includes single cell analysis technologies, applications, industries, major funding initiatives, patents and companies. The market sizes for single cell products are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).
This report reviews the single cell workflow steps and technologies and provides background on why single cell analysis is important. It then discusses some of the top research initiatives that are contributing to single cell applications. Market driving forces are also discussed.
The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from Jan. 2016 to Sept. 2017. Industry subsectors analyzed include target enrichment, droplet digital PCR, single cell DNA polymerase, DNA amplification, next generation sequencing (NGS) instruments, single cell proteomics, circulating tumor cell (CTC) capture and detection, liquid biopsy, preimplantation testing and immune sequencing.
The market for single cell analysis technologies is analyzed in depth. The market is analyzed by end user, application field, product type, omics method used, cell type, clinical indication and geography.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the rest of the world.
Market data covers the years 2015, 2016, 2017 (estimated) and 2022 (forecast).
More than 90 companies in the single cell analysis industry are profiled in this report.
WGR Research provides a summary of the main industry acquisitions and strategic alliances from Jan. 2016 through Sept. 2017, including key alliance trends.
Accelerate Diagnostics Inc.
Agilent Technologies Inc.
Ambry Genetics
Angle Plc
Apocell Inc.
Asuragen Inc.
Atreca Inc.
Aviva Biosciences
Becton, Dickinson And Co.
Berry Genomics Co. Ltd.
Bgi Shenzhen
Bio-Rad Laboratories Inc.
Bio-Techne Ltd.
Bioarray S.L.
Biocept Inc.
Biofluidica Inc.
Boreal Genomics
Cell Microsystems Inc.
Cellular Research Inc.
Celsee Diagnostics
Chronix Biomedical
Circulomics Inc.
Cooper Surgical Inc.
Cynvenio Biosystems Inc.
Cytotrack Aps
Danaher Corp.
Diagnologix Llc
Dna Electronics Ltd.
Epic Sciences
Exosome Diagnostics Inc.
Flowjo Llc
Fluidigm Corp
Fluxion Biosciences Inc.
Ge Healthcare
Gigagen Inc.
Good Start Genetics Inc.
Htg Molecular Diagnostics Inc.
Illumina Inc.
Kellbenx Inc.
Laboratory Corp. Of America Inc.
Menarini Silicon Biosystems
Merck Kgaa
Namocell Inc.
Nanocellect Biomedical Inc.
Nanostring Technologies Inc.
Natera Inc.
New Oncology Gmbh
Nodality Inc.
Nugen Technologies Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences Of California Inc.
Perkinelmer Inc.
Qiagen Nv
Rarecells Sas
Rarecyte Inc.
Resolution Bioscience Inc.
Roche Holding Ag
Royal Philips
Screencell
Sengenics International Pte Ltd.
Sphere Fluidics Ltd.
Stratec Biomedical Ag
Sysmex Corp.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Thorne Diagnostics Inc.
Trovagene Inc.
Vitatex Inc.
Yikon Genomics Co. Ltd.
Continued…
Leave a Query @ https://www.wiseguyreports.com/enquiry/3163483-single-cell-omics-emerging-technologies-and-markets
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
